Needham & Company Raises Price Target on Synopsys (SNPS) Following 4Q
Get Alerts SNPS Hot Sheet
Rating Summary:
25 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 2 | New: 2
Join SI Premium – FREE
Needham & Company reiterated a Buy rating on Synopsys (NASDAQ: SNPS), and raised the price target to $66.00 (from $60.00), following the company's 4Q earnings report. Results, including revenue of $633.7MM and NG EPS of $0.77, exceeded consensus of $628.4MM and $0.75, respectively. SNPS provided initial F17 guidance calling for revenue of $2.57-2.60B, above consensus of $2.54B, and NG EPS of $3.16-3.23, below consensus $3.25.
Analyst Richard Valera commented, "SNPS delivered strong 4Q results, capping off a year in which the company solidly exceeded its initial revenue, EPS and CFO guidance, and it offered initial F17 guidance that we view as roughly in line with consensus adjusted for its recent acquisitions. While the company's down y/y backlog despite an increase in duration will likely raise some questions (and possibly put some pressure on the shares), we're inclined to give SNPS the benefit of the doubt given its strong recent execution track record. As such, we'd be buyers on any post-earnings weakness. We maintain our Buy and raise our PT to $66 (was $60), or ~17x ex -cash F18 NG EPS."
For an analyst ratings summary and ratings history on Synopsys click here. For more ratings news on Synopsys click here.
Shares of Synopsys closed at $60.48 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades QIAGEN NV (QIA:GR) (QGEN) to Overweight
- Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
- HDFC Asset Management Co Ltd (HDFCAMC:IN) PT Raised to INR3,250 at JPMorgan
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Needham & Company, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share